US FDA declines to approve Lexicon Pharma's add-on diabetes drug

Lexicon Pharmaceuticals

20/12/2024 21:40

Dec 20 (Reuters) - The U.S. Food and Drug Administration
declined to approve Lexicon Pharmaceuticals'  LXRX.O  add-on
drug for type 1 diabetes and chronic kidney disease, the company
said on Friday.

 (Reporting by Puyaan Singh and Sriparna Roy in Bengaluru;
Editing by Shreya Biswas)
 ((Puyaan.Singh@thomsonreuters.com;))